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The modified precipitation method [3-6] is method of 
encapsulating hydrophilic drugs, especially protein and peptide 
ones, into microspheres. Since the release profiles of proteins 
dominantly depend on the nature and morphology of the polymer, 
drug distribution within microspheres and release temperature, the 
fabrication of microspheres with specific morphology and drug 
distribution is a challenge for chemical engineers [7]. PDLLA
 
 
microspheres can protect proteins against biological inactivation 
and can ensure their release for long time frames, and at specified 
time. Finally, the size of the particles can be used to passively 
target the delivery vehicles for uptake by specific types of cells, 
such as professional antigen-presenting cells, or to target specific 
tissues [8].
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HRP-loaded PDLLA particles were successfully obtained by
 
 
precipitation method. PDLLA-HRP particles, prepared by
 
 
modified precipitation method, have perfectly spherical shape, 
smooth surface and are non-agglomerated. In addition, the 
optimal particles were obtained with ethanol and 5% PVA.  The 
mean diameter of the particles is
 
530 nm, and encapsulation 
efficiency is
 
46 %.
 
The main advantage of this method is that it 
does not require an increase in temperature and, therefore, 
may be useful when the heat-sensitive drugs, like proteins, are 
used.
Poly-D,L-lactide with an average molecular weight of 50,000 g/mol
 
was purchased from Sigma (Sigma-Aldrich, 
Germany). Horseradish peroxidase (HRP) with molecular weight of 45 kDa was used as model protein.
 
 
Microspheres were prepared by modified precipitation method
 
[4].
 
The following parameters were varied: co-
 
solvent  was methanol or ethanol and the surfactant concentration was 1% w/v or 5% w/v. Individual
 
 
preparations were repeated at least three times. Briefly, the method was performed as follows: 40 mg of 
commercial granules PDLLA (SIGMA-Aldrich, Germany) were dissolved in chlorophorm, and 1 mg of HRP
 
was 
dissolved in 1 ml of water. This mixture was added to methanol or ethanol to form a dispersion. This dispersion 
was added dropwise to 20 ml PVA
 
solution containing 1 wt% or 5 wt% of  PVA while the mixture was stirred  at 
1200 rpm using magnetic stirrer.  After that, solution was homogenized 10 min on 25 000 rpm, centrifuged 2 
hours on 4000 rpm, decanted and vacuum dried. 
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Fig.
 
1.
 
SEM images of HRP-loaded PDLLA spheres:  a) batch 1. ((a) and (d)) (co-solvent ethanol and 1% w/v PVA), b) batch 2. ((b) and (e)) 
(co-solvent methanol and 5% w/v PVA, c) batch 3. ((c) and (f)) (co--solvent ethanol and 5% w/v PVA) and d)
 
FESEM images of HRP-loaded 
PDLLA spheres-batch 3. ((g), (h) and (i)) (co-solvent ethanol and 5% w/vPVA)
Fig. 4. DSC diagrams of  PDLLA powder 
and PDLLA-HRP powder
Fig. 5. XRD diagrams of PDLLA, HRP and 
PDLLA-HRP powder
PDLLA
 
+
HRP
(Batch)
Feret X (nm) Feret Y (nm) Dmax (nm)
Min Max Mean Min Max Mean Min Max Mean
1. 240 1980 780
±340
300 2230 800
±400
390 2830 1130
±520
2. 80 600 300
±90
110 720 350
±110
140 940 460
±140
3. 120 820 360
±120
100 810 360
±130
180 1003 530
±170
Table 1. Results of stereological analysis
Fig.
 
2. Results of stereological analysis
Fig.
 
3. Spectrophotometric  analysis of PDLLA-HRP powder  prepared by precipitation 
method
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The aim of this study was to produce HRP loaded PDLLA
 
 
spheres
 
with the best properties for controlled and sustained delivery of 
HRP. The ability to control the size of PDLLA spheres with incorporated 
HRP, should facilitate the investigations of their scope for
 
applicability in 
drug delivery [9].
 
We have investigated the key parameters to fabricate 
PDLLA spheres containing HRP as a model protein using the modified 
precipitation method. Various factors that influence the size and
 
 
morphology of particles, encapsulation efficiency and initial release were 
varied.
 
From the results obtained through the stereological examination 
we can see that particles from the first series are larger, having a size 
distribution with mean diameter of 1130 nm. (Fig. 2. (a-c) and Table 1.). 
The particles from the second and the third series are smaller, with 
mean diameter of 460 nm (Fig. 2. (d-f) and  Table 1.) and 530 nm (Fig. 
2. (g-i) and Table 1.). From the SEM images (Fig. 1. (a-f)) and FESEM 
images (Fig. 1. (g-i)) we can see
 
that all PDLLA-HRP particles, prepared 
by modified precipitation method, have perfectly spherical shape,
 
 
smooth surface and are non-agglomerated. The average diameter of the
 
optimal
 
PDLLA-HRP spheres, prepared by precipitation method is 530 
nm (Table 1.). The UV spectroscopy has been used to estimate
 
 
encapsulation efficiency of HRP loaded PDLLA particles (Fig. 3.). From 
the spectrophotometric analysis (Fig. 3.), the encapsulation efficiency of 
46% is calculated. Differential scanning calorimetry (DSC)
 
(Fig. 4.) and 
X-ray diffraction (XRD)
 
(Fig. 5.) were used to characterize the particles.
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Injectable poly-D,L-lactide (PDLLA)
 
microspheres containing proteins or
 
 
peptides as controlled release devices
 
 
have been widely used for the treatment of 
human diseases and animal health.
 
 
Fundamental understanding of the
 
 
relationship among the size of 
microspheres, encapsulation efficiency and 
protein release capacity are essential for 
the design of microsphere delivery
 
 
systems [1,2].
